BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Journo XB, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen MI, Gisbertz SS, O'Neill JR, Hoelscher A, Piessen G, van Lanschot J, Wijnhoven B, Jobe B, Davies A, Schneider PM, Pera M, Nilsson M, Nafteux P, Kitagawa Y, Morse CR, Hofstetter W, Molena D, So JB, Immanuel A, Parsons SL, Larsen MH, Dolan JP, Wood SG, Maynard N, Smithers M, Puig S, Law S, Wong I, Kennedy A, KangNing W, Reynolds JV, Pramesh CS, Ferguson M, Darling G, Schröder W, Bludau M, Underwood T, van Hillegersberg R, Chang A, Cecconello I, Ribeiro U Jr, de Manzoni G, Rosati R, Kuppusamy M, Thomas PA, Low DE; International Esodata Study Group. Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer. JAMA Surg 2021;156:836-45. [PMID: 34160587 DOI: 10.1001/jamasurg.2021.2376] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Fumagalli Romario U, de Pascale S; IEO Group for Upper GI Surgery. Esophagectomy-prevention of complications-tips and tricks for the preoperative, intraoperative and postoperative stage. Updates Surg 2023;75:343-55. [PMID: 35851675 DOI: 10.1007/s13304-022-01332-3] [Reference Citation Analysis]
2 Matsuda S, Kitagawa Y, Okui J, Okamura A, Kawakubo H, Takemura R, Muto M, Kakeji Y, Takeuchi H, Watanabe M, Doki Y. Old age and intense chemotherapy exacerbate negative prognostic impact of postoperative complication on survival in patients with esophageal cancer who received neoadjuvant therapy: a nationwide study from 85 Japanese esophageal centers. Esophagus 2023. [PMID: 36662353 DOI: 10.1007/s10388-022-00980-z] [Reference Citation Analysis]
3 de Groot EM, Goense L, Kingma BF, Haverkamp L, Ruurda JP, van Hillegersberg R. Trends in surgical techniques for the treatment of esophageal and gastroesophageal junction cancer: the 2022 update. Dis Esophagus 2023:doac099. [PMID: 36636763 DOI: 10.1093/dote/doac099] [Reference Citation Analysis]
4 Anoldo P, Vertaldi S, Manigrasso M, D'Amore A, De Palma GD, Milone M. Re-thoracoscopy for the management of gastric conduit dehiscence after minimally invasive McKeown esophagectomy. Int J Surg Case Rep 2023;103:107876. [PMID: 36640467 DOI: 10.1016/j.ijscr.2023.107876] [Reference Citation Analysis]
5 Linde P, Mallmann M, Adams A, Wegen S, Fan J, Rosenbrock J, Trommer M, Marnitz S, Baues C, Celik E. The Role of Age and Comorbidities in Esophagogastric Cancer Chemoradiation of the Frail Elderly (>70 Years): An Analysis from a Tertiary High Volume-Center. Cancers (Basel) 2022;15. [PMID: 36612103 DOI: 10.3390/cancers15010106] [Reference Citation Analysis]
6 Ubels S, Klarenbeek B, Verstegen M, Bouwense S, Griffiths EA, van Workum F, Rosman C, Hannink G; the TENTACLE—Esophagus Collaborative Group. Predicting mortality in patients with anastomotic leak after esophagectomy: development of a prediction model using data from the TENTACLE-Esophagus study. Dis Esophagus 2022:doac081. [PMID: 36461788 DOI: 10.1093/dote/doac081] [Reference Citation Analysis]
7 Qu RZ, Ma YP, Bao XY, Tao LY, Zhou X, Lu SY, Zhang Y, Wang BY, Li F, Tuo L, Zhang ZP, Fu W. Features of gastric cancer by anatomic subsite in northern China: A multi-center Health Science Report database study. World J Gastrointest Oncol 2022; 14(11): 2238-2252 [DOI: 10.4251/wjgo.v14.i11.2238] [Reference Citation Analysis]
8 Wong CK, Joseph K, Turner SR. Treatment Options for Patients With Persistent Disease After Initial Endotherapy for Esophageal Neoplasia. Foregut 2022;2:123-131. [DOI: 10.1177/26345161221115360] [Reference Citation Analysis]
9 Cheng J, Guo M, Yang Y, Liu Y, Hu W, Shang Q, Li C, Xia L, Wang Y, Wang W, Tian D, Yuan Y, Hu Y, Chen L. Perioperative Outcomes of Minimally Invasive Esophagectomy After Neoadjuvant Immunotherapy for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma. Front Immunol 2022;13:848881. [DOI: 10.3389/fimmu.2022.848881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Matsuda S, Kawakubo H, Irino T, Kitagawa Y. Role sharing between minimally invasive oesophagectomy and organ preservation approach for surgically resectable advanced oesophageal cancer. Jpn J Clin Oncol 2021:hyab192. [PMID: 34891170 DOI: 10.1093/jjco/hyab192] [Reference Citation Analysis]
11 Schröder W, Gisbertz SS, Voeten DM, Gutschow CA, Fuchs HF, van Berge Henegouwen MI. Surgical Therapy of Esophageal Adenocarcinoma-Current Standards and Future Perspectives. Cancers (Basel) 2021;13:5834. [PMID: 34830988 DOI: 10.3390/cancers13225834] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 McCaw ZR, Wei LJ. Questions About a Risk Prediction Model of Mortality After Esophagectomy for Cancer. JAMA Surg 2021. [PMID: 34730807 DOI: 10.1001/jamasurg.2021.5701] [Reference Citation Analysis]
13 Braillon A. Questions About a Risk Prediction Model of Mortality After Esophagectomy for Cancer. JAMA Surg 2021. [PMID: 34730796 DOI: 10.1001/jamasurg.2021.5698] [Reference Citation Analysis]
14 . Error in a Supplement. JAMA Surg 2021;156:894. [PMID: 34495318 DOI: 10.1001/jamasurg.2021.4340] [Reference Citation Analysis]